{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:36:22Z","timestamp":1782246982567,"version":"3.54.5"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Monit Comput"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10877-021-00692-2","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T09:02:21Z","timestamp":1616317341000},"page":"587-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Extravascular leakage of induction doses of rocuronium: four cases in which both depth of neuromuscular block and plasma concentration of rocuronium were assessed"],"prefix":"10.1007","volume":"36","author":[{"given":"Shunichi","family":"Takagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Doshu-Kajiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0591-3445","authenticated-orcid":false,"given":"Takahiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,21]]},"reference":[{"key":"692_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/00000542-199206000-00026","volume":"76","author":"H Iwasaki","year":"1992","unstructured":"Iwasaki H, Namiki A, Omote T, Omote K. Neuromuscular effects of subcutaneous administration of pancuronium. Anesthesiology. 1992;76:1049\u201351.","journal-title":"Anesthesiology"},{"key":"692_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/bja\/aem402","volume":"100","author":"G Cammu","year":"2008","unstructured":"Cammu G, De Kam PJ, Demeyer I, Decoopman M, Peeters PAM, Smeets JMW, Foubert L. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Br J Anaesth. 2008;100:373\u20139.","journal-title":"Br J Anaesth"},{"key":"692_CR3","first-page":"754","volume":"80","author":"T Magorian","year":"1995","unstructured":"Magorian T, Wood P, Caldwell J, et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg. 1995;80:754\u20139.","journal-title":"Anesth Analg"},{"key":"692_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/bja\/ael142","volume":"97","author":"T Suzuki","year":"2006","unstructured":"Suzuki T, Masaki G, Ogawa S. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. Br J Anaesth. 2006;97:160\u20133.","journal-title":"Br J Anaesth"},{"key":"692_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1213\/00000539-200302000-00027","volume":"96","author":"KS Kim","year":"2003","unstructured":"Kim KS, Jeon JW, Koh MS, Shim JH, Cho SY, Suh JK. The duration of immobilization causes the changing pharmacodynamics of mivacurium and rocuronium in rabbits. Anesth Analg. 2003;96:438\u201342.","journal-title":"Anesth Analg"},{"key":"692_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/bja\/80.3.386","volume":"80","author":"JJ Driessen","year":"1998","unstructured":"Driessen JJ, Robertson EN, Booij LH, Vree TB. Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone. Br J Anaesth. 1998;80:386\u20138.","journal-title":"Br J Anaesth"},{"key":"692_CR7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00540-015-1991-2","volume":"29","author":"T Moriyama","year":"2015","unstructured":"Moriyama T, Matsunaga A, Nagata O, et al. Effective method of continuous rocuronium administration based on effect-site concentrations using a pharmacokinetic\/pharmacodynamic model during propofol\u2013remifentanil anesthesia. J Anesth. 2015;29:593\u20139.","journal-title":"J Anesth"},{"key":"692_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1213\/XAA.0000000000000934","volume":"12","author":"SR Navare","year":"2019","unstructured":"Navare SR, Garcia Medina O, Prielipp RC, Weinkauf JL. Sugammadex reversal of a large subcutaneous depot of rocuronium in a dialysis patient: a case report. A A Pract. 2019;12:375\u20137.","journal-title":"A A Pract"}],"container-title":["Journal of Clinical Monitoring and Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-021-00692-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10877-021-00692-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-021-00692-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:55:41Z","timestamp":1693518941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10877-021-00692-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,21]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["692"],"URL":"https:\/\/doi.org\/10.1007\/s10877-021-00692-2","relation":{},"ISSN":["1387-1307","1573-2614"],"issn-type":[{"value":"1387-1307","type":"print"},{"value":"1573-2614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,21]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Takagi S, Iwasaki H and Suzuki T have received speaker fees from MSD Inc., JAPAN.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all the patients or their close relatives.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Patients signed informed consent regarding publishing their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}